PATENT—FED. CIR.: PTAB RULING INVALIDATING INJECTION-PEN PATENT REVERSED
(C.C.H.)
•
By George Basharis, J.D.
•
Copyright (c) CCH INCORPORATED, A Wolters Kluwer business. All rights reserved.
•
IP Law Daily
•
News: Story
Wolters Kluwer Intellectual Property Law Daily
•
May 09, 2023
The Board's finding that Sanofi-Aventis' patent for a pen-type injection device was invalid as obvious over prior art was not supported by substantial evidence.
The U.S. Court of Appeals for the Federal Circuit has reversed a decision by the Patent...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.